By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Flow cytometry technology firm LeukoDx today announced it has secured commitments of up to $8 million in investments during the next three years.

The funding is expected to bring the company's development of its point-of-care platform to the point of registration, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.